Close Menu

Rising Costs

It's no secret that pharmaceutical companies are having problems filling their pipelines, says Pharmalot's Ed Silverman. On top of slashing R&D budgets, many companies are now finding that the cost of clinical trials is on the rise, across all phases. "There is increasing competition for trial sites and clinical research organizations that can yield reliable, high quality data," Silverman says.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A small, early-stage trial of a combination therapy for brain cancer reports favorable responses in two patients, according to the Guardian.

Nature News writes that viral genomic surveillance in the US faces systemic issues.

President Joe Biden is seeking an increase in federal spending, including higher budgets for the National Institutes of Health and Centers for Disease Control and Prevention.

In PLOS this week: sex-stratified genome-wide association study of chronic pain, sequencing data from Indigenous Mexican groups, and more.